SCHEMBL30640822

SCHEMBL30640822

Cc1cc([N+](=O)[O-])c(OC2CC2)cc1C1=CCNCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 6/20 0.43
▸ HTR2A P28223 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ HTR2C P28335 3/20 0.34
▸ HSD17B10 Q99714 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ HTR1D P28221 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ BRCA1 P38398 1/20 0.34
▸ TBK1 Q9UHD2 1/20 0.33
▸ ALK Q9UM73 2/20 0.32
▸ QDPR P09417 1/20 0.32
▸ TGFBR1 P36897 1/20 0.32
▸ ACVR1 Q04771 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17304107 1.00 HTR6 (0.43) HTR6HTR2AKDM4EALDH1A1HTR2C
SCHEMBL18698393 0.88 HTR6 (0.34) HTR6HTR2AALDH1A1TBK1ALK
SCHEMBL19174976 0.86 HTR6 (0.43) HTR6HTR2AKDM4EALDH1A1HTR2C
SCHEMBL26041932 0.84 HTR6 (0.39) HTR6HTR2AKDM4EALDH1A1HTR2C
SCHEMBL17304117 0.84 BRD4 (0.41) HTR6HTR2AKDM4EALDH1A1HTR2C
SCHEMBL19556801 0.83 HTR6 (0.41) HTR6HTR2AKDM4EALDH1A1HTR2C
SCHEMBL31017571 0.83 HTR6 (0.41) HTR6HTR2AKDM4EALDH1A1HTR2C
SCHEMBL18698403 0.80 BCL6 (0.34) HTR2AHTR2CALKBCL6BCOR
SCHEMBL19557720 0.80 HTR6 (0.39) HTR6HTR2AKDM4EALDH1A1HTR2C
SCHEMBL17304076 0.80 PDE3B (0.35) ALDH1A1MEN1KMT2AMAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3150592-B1 ALK KINASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF SHANGHAI EMERALD WELLCARES PHARMACEUTICAL CO LTD (CN) 2023-08-30 — — EP disclosed
Send feedback